A Phase I Trial of Sarcosinamide Nitrosourea (SarCNU) in Patients With Solid Tumors

Trial Profile

A Phase I Trial of Sarcosinamide Nitrosourea (SarCNU) in Patients With Solid Tumors

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Jan 2013

At a glance

  • Drugs NSC 364432 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Jan 2013 Actual end date Sep 2005 added as reported by ClinicalTrials.gov.
    • 31 Jan 2013 Actual initiation date changed from Nov 1999 to Aug 1999 as reported by ClinicalTrials.gov.
    • 11 Jan 2007 Status changed from in progress to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top